Filing Details
- Accession Number:
- 0001209191-23-023758
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-04-07 15:47:21
- Reporting Period:
- 2023-04-05
- Accepted Time:
- 2023-04-07 15:47:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1851194 | Ventyx Biosciences Inc. | VTYX | Pharmaceutical Preparations (2834) | 832996852 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1878125 | Raju Mohan | C/O Ventyx Biosciences, Inc. 662 Encinitas Blvd., Ste. 250 Encinitas CA 92024 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-04-05 | 10,165 | $29.61 | 1,592,961 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-04-05 | 3,065 | $30.49 | 1,589,896 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-04-06 | 7,515 | $29.01 | 1,582,381 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 28, 2022.
- Represents the weighted average share price of an aggregate total of 10,165 shares sold in the price range of $29.00 to $29.9994. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Represents the weighted average share price of an aggregate total of 3,065 shares sold in the price range of $30.0008 to $30.835. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Represents the weighted average share price of an aggregate total of 7,515 shares sold in the price range of $29.00 to $29.085. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
